British Drugmaker, Oxford University Say COVID-19 Vaccine Shows 70 Percent Efficacy

0
275
An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on November 17, 2020. JUSTIN TALLIS / AFP
An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca, on November 17, 2020. JUSTIN TALLIS / AFP

British drugs group AstraZeneca and the University of Oxford on Monday said their jointly-developed vaccine against Covid-19 has shown “an average efficacy of 70 percent” in trials.

“This vaccine’s efficacy and safety confirm that it will be highly effective against Covid-19 and will have an immediate impact on this public health emergency,” AstraZeneca chief executive Pascal Soriot said in a statement.

However, the vaccine has produced lower average efficacy compared with coronavirus vaccines produced by rivals Pfizer/BioNTech and Moderna which have come in above 90 percent.

More to follow . . . 

See also  COVID-19 Deaths In US Cross 200,000

LEAVE A REPLY

Please enter your comment!
Please enter your name here